Answers are grounded in this paper and cite their sources.
Long-read genomic sequencing unveils a 1.6 kb deletion impacting DDX11 in siblings with Warsaw breakage syndrome, indicating a need for broader genomic interrogation.
Currently, exome and genome sequencing achieve a diagnostic rate of 30%-50% for rare genetic diseases. With multi-modal technologies profiling the genome, transcriptome, and epigenome, interrogation of genomic elements outside of protein-coding regions shows potential to improve this as demonstrated herein. Siblings with sensorineural hearing loss, microcephaly, intellectual impairment, and growth restriction were seen in consultation. Following extensive clinical testing, long-read whole genome and cDNA-based transcriptome sequencing on the Oxford Nanopore platform identified a homozygous 1.6 kb deletion of the 5' UTR and promoter region of DDX11, a gene associated with Warsaw breakage syndrome. The deletion included the hypomethylated CpG island regulating DDX11, led to a loss of expression of DDX11 mRNA and protein, and resulted in the characteristic "railroad chromosome." Identifying a causal variant for this family required expanding the search space for genomic variants beyond protein-coding regions, and multi-modal data integration enabled a more holistic approach to variant prioritization and classification prior to pursuing targeted protein and functional assays. This multi-modal genome-wide approach heralds promise for patients on the diagnostic odyssey and who have exhausted standard of care testing.
No takes yet. Share an insight, caveat, or question.
Dubois et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: